Claims involving breast cancer diagnosis have been the leading cause of malpractice litigation for many years. The majority of plaintiffs were pre-menopausal women. The fundamental allegation in the majority of claims is delay in diagnosis.
The 2002 Breast Cancer Study, authorized by the Physician Insurers Association of America (PIAA), examined breast cancer claims and found that Ob-Gyns were second only to radiologists as the physician group affected by litigation, accounting for 44 percent of all claims alleging delay of breast cancer diagnosis.
A routinely documented test of breast health beyond the current standard of a clinical breast examination may prove to be beneficial for the Ob-Gyn practice. Routine NAF assessment may provide this objective documentation.
Download PIAA Study (pdf)